bioAffinity Technologies, Inc. (BIAF)
USD 1.04
(1.96%)
USD 1.04
(1.96%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.57 Million USD | 527.08% |
| 2022 | 251.74 Thousand USD | -97.78% |
| 2021 | 11.36 Million USD | 13.57% |
| 2020 | 10 Million USD | 149.48% |
| 2019 | 4.01 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.38 Million USD | -7.68% |
| 2024 Q1 | 1.49 Million USD | -5.32% |
| 2023 Q4 | 1.57 Million USD | -6.37% |
| 2023 FY | 1.57 Million USD | 527.08% |
| 2023 Q2 | 42.33 Thousand USD | -74.87% |
| 2023 Q1 | 168.43 Thousand USD | -33.1% |
| 2023 Q3 | 1.68 Million USD | 3882.88% |
| 2022 Q2 | 11.12 Million USD | -6.73% |
| 2022 Q1 | 11.92 Million USD | 4.94% |
| 2022 FY | 251.74 Thousand USD | -97.78% |
| 2022 Q4 | 251.74 Thousand USD | -69.12% |
| 2022 Q3 | 815.11 Thousand USD | -92.67% |
| 2021 Q4 | 11.36 Million USD | 9.27% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q3 | 10.4 Million USD | 0.0% |
| 2021 FY | 11.36 Million USD | 13.57% |
| 2020 FY | 10 Million USD | 149.48% |
| 2020 Q4 | 10 Million USD | 0.0% |
| 2019 FY | 4.01 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 87.94 Million USD | 98.205% |
| Prenetics Global Limited | 2.36 Million USD | 33.374% |
| Star Equity Holdings, Inc. | 3.6 Million USD | 56.258% |
| CareDx, Inc | 34.22 Million USD | 95.387% |
| Exact Sciences Corporation | 2.55 Billion USD | 99.938% |
| Exagen Inc. | 23.72 Million USD | 93.345% |
| Inotiv, Inc. | 417.64 Million USD | 99.622% |
| Guardant Health, Inc. | 1.35 Billion USD | 99.883% |
| Biodesix, Inc. | 60.69 Million USD | 97.399% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -1083.432% |
| Precipio, Inc. | 1.11 Million USD | -41.455% |
| iSpecimen Inc. | 196.24 Thousand USD | -704.427% |
| Natera, Inc. | 441.99 Million USD | 99.643% |
| Aspira Women's Health Inc. | 2.26 Million USD | 30.334% |
| Standard BioTools Inc. | 98.21 Million USD | 98.393% |
| 23andMe Holding Co. | 76.51 Million USD | 97.937% |
| Castle Biosciences, Inc. | 15.31 Million USD | 89.689% |
| Personalis, Inc. | 48.96 Million USD | 96.776% |
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -270.573% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -27.54% |
| OpGen, Inc. | 13.04 Million USD | 87.897% |
| T2 Biosystems, Inc. | 49.49 Million USD | 96.811% |
| Myriad Genetics, Inc. | 145 Million USD | 98.911% |
| ICON Public Limited Company | 3.93 Billion USD | 99.96% |
| NeoGenomics, Inc. | 611.67 Million USD | 99.742% |
| Star Equity Holdings, Inc. | 3.6 Million USD | 56.258% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 99.833% |
| RadNet, Inc. | 1.49 Billion USD | 99.894% |
| MDxHealth SA | 41.26 Million USD | 96.174% |
| Psychemedics Corporation | 2.29 Million USD | 31.304% |
| Illumina, Inc. | 2.26 Billion USD | 99.93% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 94.06 Million USD | 98.322% |
| DarioHealth Corp. | 29.54 Million USD | 94.656% |
| Fulgent Genetics, Inc. | 14.9 Million USD | 89.41% |
| Sera Prognostics, Inc. | 1.85 Million USD | 15.036% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -300.26% |
| OPKO Health, Inc. | 326.56 Million USD | 99.517% |
| Medpace Holdings, Inc. | 142.12 Million USD | 98.889% |
| Neogen Corporation | 906.23 Million USD | 99.826% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -81.153% |
| Prenetics Global Limited | 2.36 Million USD | 33.374% |
| Mainz Biomed B.V. | 7.42 Million USD | 78.727% |
| Trinity Biotech plc | 67.42 Million USD | 97.659% |
| Neuronetics, Inc. | 62.47 Million USD | 97.473% |
| Sotera Health Company | 2.32 Billion USD | 99.932% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | 0.0% |